Search

everythinglearnresearchcommunity

for

Search:↓

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

A mouse gene mutation increases the risk of skin cancer.

Stem cell differentiation is crucial for skin barrier maintenance and its disruption can lead to skin diseases.

Niosomes are a promising and effective way to deliver drugs through the skin.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Blocking YAP/TAZ could be a new way to treat skin cancer.

UV exposure reduces Lgr6+ stem cells in mouse skin and they don't significantly contribute to skin cancer development.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Vav2 and Vav3 proteins help control skin stem cell numbers and activity in both healthy and cancerous cells.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

The conclusion is that proper communication about the realistic effects of hair loss and skin aging treatments can improve dermatologists' credibility.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.